These observations differ from studies conducted in tumors induced with parental TC-1 cells, as targeting either IL-10 or TGF-β enhanced the therapeutic effect of various immunotherapies or increased infiltration with an anti-tumor cell population in these tumors [61,62,63]. This evidence concerns the gene IL10 and neoplasm.